NCT06761547

Brief Summary

Tonsillectomy is one of the most common surgeries in children which is associated with many morbidities such as postoperative pain, nausea, vomiting, bleeding and laryngospasm . Laryngospasm is a dangerous complication of tonsillectomy that occurs following tracheal extubation It is characterized by a strong, involuntary contraction of the laryngeal muscles, it's frequency in children is higher than adults due to their narrow upper airways that can be blocked following edema and inflammation The incidence of laryngospasm is 17 per 1000 children younger than nine years old, which increases to 96 per 1000 children with upper respiratory tract infections There are several ways to prevent this complication, including complete haemostasis during surgery, gentle suctioning of the oropharynx before extubation and the use of drugs as intravenous or topical lidocaine, propofol and etc . Postoperative pain control after the tonsillectomy has a very important role in recovery time, hospitalization duration, bleeding, nausea and vomiting. Lidocaine is an antiarrhythmic drug and its main mechanism of action is blocking voltage-gated Na+ channels that inhibit the activity of the upper laryngeal nerve and reduces the long-term blockage of the glottis . Magnesium sulphate has a calcium antagonist property, which provides muscle relaxation and increases flaccidity. It also has an antagonistic action on sodium channels and N-methyl-D-aspartate receptors and reduces the release of substance P, which decreases the airway reactivity and stress responses . Therefore we decided to compare the effect of intravenous injection of magnesium sulfate and lidocaine on the prevention of laryngospasm occurrence, and analgesic requirement in tonsillectomy the goal of the study Comparing the effectiveness of magnesium sulfate and lidocaine in prevention of post tonsillectomy complication .

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at below P25 for phase_3

Timeline
10mo left

Started Mar 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Mar 2025Mar 2027

First Submitted

Initial submission to the registry

January 6, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Expected
Last Updated

January 7, 2025

Status Verified

January 1, 2025

Enrollment Period

1 year

First QC Date

January 6, 2025

Last Update Submit

January 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of laryngospasm in three groups.

    Common signs of laryngospasm include inspiratory stridor which may progress to complete obstruction, increased respiratory effort, tracheal tug, paradoxical respiratory effort, oxygen desaturation with or without bradycardia, or airway obstruction which does not respond to a Guedel airway. When these occur, either alone or in combination, laryngospasm is considered

    24 hours

Study Arms (3)

Group A

ACTIVE COMPARATOR

patients will take magnsium sulfate 15 mg/kg on 50 ml saline

Drug: magnsium sulfateDrug: Saline

Group B

ACTIVE COMPARATOR

Patients will take lidocaine2% 1 mg/kg on 50 ml saline

Drug: Lidocaine (drug)Drug: Saline

Group c

PLACEBO COMPARATOR

patients will take 50 ml saline only

Drug: Saline

Interventions

patients will take magnsium sulfate 15 mg/kg IV

Group A

patients will take lidocaine2% 1 mg/kg

Group B
SalineDRUG

50 ml saline IV

Group AGroup BGroup c

Eligibility Criteria

Age3 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA physical status I-II.
  • Both sexes.
  • Age: children 3-14years old.
  • patients subjected for tonsillectomy or adeno-tonsillectomy surgery with parental consent for participation in the study.

You may not qualify if:

  • \- patients who refused to participate in this study.
  • History of allergic response to magnesium sulfate and liodcaine .
  • the Prescence of cardiovascular, respiratory and kidney diseases.
  • A recent history of upper respiratory tract infection and febrile illness.
  • History of mythenia gravis.
  • patients subjected for adeno-tonsillectomy with myringotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Stalfors J, Ericsson E, Hemlin C, Hultcrantz E, Mansson I, Roos K, Hessen Soderman AC. Tonsil surgery efficiently relieves symptoms: analysis of 54 696 patients in the National Tonsil Surgery Register in Sweden. Acta Otolaryngol. 2012 May;132(5):533-9. doi: 10.3109/00016489.2011.644252. Epub 2012 Jan 11.

    PMID: 22235871BACKGROUND

MeSH Terms

Interventions

LidocainePharmaceutical PreparationsSodium Chloride

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Central Study Contacts

Martina Monwar Shawky, residant doctor

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
residant doctor at Assiut university hospital

Study Record Dates

First Submitted

January 6, 2025

First Posted

January 7, 2025

Study Start

March 1, 2025

Primary Completion

March 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

January 7, 2025

Record last verified: 2025-01